Download presentation
Presentation is loading. Please wait.
Published byGodfrey Lawson Modified over 8 years ago
1
Hairy Cell Leukemia Variant Has Similar Survival to Classical Disease Despite Poorer Responses to Initial Therapy: A 30-Year Experience from Memorial Sloan Kettering Cancer Center by Bartlomiej Getta, Kaitlin M Woo, Sean Devlin, Jae H. Park, Omar Abdel-Wahab, and Martin S Tallman Blood Volume 126(23):1476-1476 December 3, 2015 ©2015 by American Society of Hematology
2
OS for classical and variant HCL is equal despite the shorter remission duration and more frequent need for re-treatment in HCL variant. Bartlomiej Getta et al. Blood 2015;126:1476 ©2015 by American Society of Hematology
3
Remission duration following first therapy is significantly longer in patients with classical than variant HCL. Bartlomiej Getta et al. Blood 2015;126:1476 ©2015 by American Society of Hematology
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.